Pyrimidine deoxyribonucleoside monophosphate metabolic process

pathway activity — cross-omics
GO:0009176Cross-omicsRNA → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Pyrimidine deoxyribonucleoside monophosphate metabolic process pathway is significantly associated with the RNA expression of multiple genes, with the TGCT cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are UPP1, SHMT1, and TYMP, each associated with the pathway in up to 26 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Pyrimidine deoxyribonucleoside monophosphate metabolic process activity versus UPP1 in TGCT (Pearson r = 0.53).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
TGCTUPP1 →+1.396+0.044<.001<.001326
UCSSHMT1 →+1.161+0.106<.001<.001323
KICHTYMP →+1.723+0.061<.001<.001223
ACCPFN1 →+0.756+0.064<.001<.001221
ACCPKMYT1 →+1.021+0.031.001.009122
MESOAURKB →+1.337+0.061.001<.001320
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0009176 vs UPP1 — TGCT

Per-sample scatter of Pyrimidine deoxyribonucleoside monophosphate metabolic process activity vs UPP1 in TGCT.

Explore this scatter interactively →

Exploration